V. Valayannopoulos
Genzyme
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by V. Valayannopoulos.
Journal of Neuroradiology | 2010
Nathalie Boddaert; Isabelle Desguerre; Nadia Bahi-Buisson; S. Romano; V. Valayannopoulos; Y. Saillour; D. Seidenwurm; David Grevent; Laureline Berteloot; Anne-Sophie Lebre; Monica Zilbovicius; Stéphanie Puget; Rémi Salomon; T. Attie-Bitach; Arnold Munnich; Francis Brunelle; P. de Lonlay
OBJECTIFS To propose a MRI cerebellar algorithm that may be applied to guide genetic/malformative or biochemical investigations for patients with cerebellar ataxia. PATIENTS AND METHODS Cerebral MRI of 158 patients with cerebellar ataxia and no supratentorial abnormality were examined according to a new categorization system based on posterior fossa imaging. The clinical and radiological findings were confronted to biochemical and/or genetic results using the MR cerebellar algorithm. Seven groups of cerebellar MRI pattern were described: vermian dysgenesis (n=27), cerebellar hypoplasia (n=15), hemispheric cerebellar dysgenesis (n=6), unilateral hemispheric atrophy (n=5), global cerebellar atrophy (n=84), signal abnormalities (n=11) and normal MRI (n=10). Cerebellar hypoplasia, vermian dysgenesis and hemispheric cerebellar dysgenesis groups were classified as malformative disorders. Global atrophy and signal abnormality groups were classified as metabolic disorders. RESULTS In the vermian dysgenesis group, a specific genetic diagnosis was obtained in eight children (8/27) and all of the mutated genes (AHI1 (JBS3), CEP290 (JBS5), TMEM67 (JBS6), and RPGRIP1L (JBS7)) are involved in primary cilia function. In the group of pontocerebellar hypoplasia specific genetic diagnosis was obtained in one patient (PCH2) (1/15). Thus, nine of 42 children classified as malformative disorder had a molecular diagnosis. Global atrophy and signal abnormality groups were classified as metabolic disorders, specific biochemical was obtained in 46/95 children. In global atrophy group, respiratory chain deficiency was diagnosed in 18 children (18/84). In 21 children a congenital disorders of glycosylation type 1a (CDG Ia) was diagnosed (21/84) and infantile neuroaxonale dystrophy (INAD) was diagnosed in one child. In signal abnormalities group, specific biochemical diagnosis was obtained in six out of 11 children, five children with respiratory chain deficiency and one child with sulphite oxidase deficiency. In hemispheric cerebellar dysgenesis and normal MRI groups, no biological diagnosis was found for any of the patients. In the group of unilateral hemispheric atrophy, we hypothesized a clastic prenatal injury. CONCLUSION The proposed MR cerebellar algorithm was useful to guide genetic/malformative or biochemical investigations, allowing an etiological diagnosis in 55 children.
Neurology | 2010
Marlène Rio; Anne-Sophie Lebre; P. de Lonlay; V. Valayannopoulos; Isabelle Desguerre; Jean-Louis Dufier; D Grevent; Monica Zilbovicius; C. Tréguier; Francis Brunelle; C. de Baracé; Jean Claude Kaplan; M.A. Espinase-Berrod; Christian Sainte-Rose; Stéphanie Puget; Agnès Rötig; Arnold Munnich; N. Boddaert
We report MRI periaqueductal T2 hypersignal suggestive of tectal glioma in 3 unrelated children with reduced vision and normal mental development (figure). Increased CSF lactate and optic atrophy in the first case suggested …
Archives De Pediatrie | 2008
Alice Kuster; T. Le François; J.-M. Dejode; J.-C. Roze; V. Valayannopoulos; Christine Vianey-Saban; Johannes Häberle; P. de Lonlay
Le cycle de l’uree permet l’excretion d’azote issu du metabolisme des acides amines par la conversion d’ammoniaque en uree dans le foie. Les deficits enzymatiques du cycle de l’uree (incidence cumulee : 1/8.000) se manifestent le plus souvent par une encephalopathie liee a la toxicite cerebrale de la glutamine au niveau des astrocytes. Le diagnostic precoce d’une hyperammoniemie neonatale avec mise en place de traitements epurateurs de l’azote (hemofiltration, chelateurs) peut permettre la survie de ces enfants. Une difficulte est alors l’evaluation des sequelles de cette decompensation. En dehors des criteres de gravite du coma et de l’EEG, l’IRM est mise a contribution. Il n’existe cependant que tres peu de documentations neuroradiologiques notamment en periode neonatale. Cas clinique Nous rapportons ici le cas clinique d’E.-G., nee a terme, qui a ete admise pour un tableau digestif en reanimation a J2, evoluant rapidement vers un coma. L’ammoniemie retrouvee elevee (max. 600 μmol/l) a pu etre corrigee en 48 h par hemofiltration et traitement medicamenteux. L’analyse des acides amines plasmatiques a permis le diagnostic de deficit en argininosuccinate synthetase (citrullinemie type I), confirmee par l’etude moleculaire. L’IRM a J13 montrait des anomalies en T1 et T2 des noyaux gris centraux avec hypersignal des noyaux lenticulaires predominant sur les regions pallidales associe a des anomalies de signal bilaterales symmetriques corticosouscorticales predominant en regions insulaires ayant fait evoquer la possibilite d’une necrose hemorragique. L’imagerie de controle realisee a 6 mois montrait cependant une quasi disparition de ces anomalies de signal. Le developpement psychomoteur de l’enfant a l’âge de 1 an est excellent. Conclusion Alors que l’aspect des lesions en phase precoce est assez specifique de l’atteinte neurologique par hyperammoniemie, il n’est pas forcement associe a un mauvais pronostic neurologique et peut regresser de facon quasi complete.
Molecular Genetics and Metabolism | 2008
Jean-Baptiste Arnoux; N. Boddaert; V. Valayannopoulos; S. Romano; Nadia Bahi-Buisson; Isabelle Desguerre; Y. de Keyzer; Arnold Munnich; Francis Brunelle; Nathalie Seta; M.D. Dautzenberg; P. de Lonlay
Archives De Pediatrie | 2012
Anais Brassier; Chris Ottolenghi; N. Boddaert; P. Sonigo; Tania Attié-Bitach; A.-E. Millischer-Bellaiche; Geneviève Baujat; Valérie Cormier-Daire; V. Valayannopoulos; Nathalie Seta; Monique Piraud; Bernadette Chadefaux-Vekemans; Christine Vianey-Saban; R. Froissart; P. de Lonlay
Orphanet Journal of Rare Diseases | 2017
Simon A. Jones; Sandra Rojas-Caro; Anthony G. Quinn; Mark Friedman; Sachin Marulkar; Fatih Süheyl Ezgü; Osama K. Zaki; J. Jay Gargus; Joanne Hughes; Dominique Plantaz; Roshni Vara; Stephen Eckert; Jean Baptiste Arnoux; Anais Brassier; Kim Hanh Le Quan Sang; V. Valayannopoulos
Archives De Pediatrie | 2009
V. Valayannopoulos; Jean-Baptiste Arnoux; Marlène Rio; P. de Lonlay
Journal of Inherited Metabolic Disease | 2017
Stéphanie Paquay; Agnès Bourillon; Samia Pichard; Jean-François Benoist; Pascale de Lonlay; Dries Dobbelaere; Alain Fouilhoux; Nathalie Guffon; Isabelle Rouvet; F. Labarthe; Guy Touati; V. Valayannopoulos; Hélène Ogier de Baulny; Monique Elmaleh-Bergès; C. Acquaviva-Bourdain; Christine Vianey-Saban; Manuel Schiff
EMC - Pédiatrie - Maladies infectieuses | 2008
P de Lonlay; V. Valayannopoulos; Sandrine Dubois
Orphanet Journal of Rare Diseases | 2018
Anupam Chakrapani; V. Valayannopoulos; Nuria Garcia Segarra; Mireia Del Toro; Maria Alice Donati; Angeles Garcia-Cazorla; María Julieta González; Celine Plisson; Vincenzo Giordano